Clinical Trials Sponsored by ARCEDI Biotech

Total 1974 results

Shanghai Henlius Biotech

Withdrawn

Evaluate the Efficacy and Safety of HLX01 Versus Mabthera in Patients With Low Tumour Burden Follicular Lymphoma.

CD20-positive Follicular Lymphoma, With Low Tumour Burden
Steba Biotech S.A.

Withdrawn

Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer

Localized Prostate Cancer

United States
HOB Biotech Group

Withdrawn

Clinical Performance of BioCLIA Ro60

Systemic Lupus Erythematosus | Sjogren's Syndrome

United States
NKGen Biotech, Inc.

Completed

Autologous Natural Killer Cells in Subjects With Plaque Psoriasis

Plaque Psoriasis

Mexico
Archigen Biotech Limited

Completed

PK, PD, Safety, and Efficacy of SAIT101 Versus MabThera® Versus Rituxan® in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United States, Korea, Republic of, Hungary, Poland, Czechia, Spain, Bosnia and Herzegovina, Bulgaria, Germany, India, Mexico
Gedea Biotech AB

Completed

Clinical Performance of a Vaginal Pessary (pHyph) in Vulvovaginal Candidiasis

Vulvovaginal Candidiasis

Sweden
JHL Biotech, Inc.

Terminated

A Study of JHL1101 Versus MabThera® in Subjects With Severe Rheumatoid Arthritis

Arthritis, Rheumatoid | Rheumatoid Arthritis

Bosnia and Herzegovina, Bulgaria, Czechia, Germany, Hungary, Lithuania, Poland, Russian Federation, Taiwan, Ukraine, United Kingdom
JHL Biotech, Inc.

Completed

A Comparative Safety and Pharmacokinetic Study of JHL1922 and Pulmozyme® in Healthy Subjects

Healthy Subjects

Netherlands
PCI Biotech AS

Completed

A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas

Cholangiocarcinoma

Germany, France, Norway, United Kingdom
PCI Biotech AS

Completed

Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant

Healthy Volunteer

United Kingdom
Steba Biotech S.A.

Completed

Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance. (PCM301)

Prostate Cancer

Spain, France, Germany, Netherlands, United Kingdom, Belgium, Finland, Italy, Sweden, Switzerland
PCI Biotech AS

Completed

Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer

Head and Neck Neoplasms | Skin Neoplasms

United Kingdom
ASIT Biotech S.A.

Unknown

Clinical Efficacy and Safety of Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis

Hay Fever
Steba Biotech S.A.

Terminated

Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD

Macular Degeneration | Choroidal Neovascularization

United States, France
SciVision Biotech Inc.

Completed

The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain

Osteoarthritis, Knee
Fertility Biotech AG

Completed

Comparative Pharmacokinetics of AFOLIA and US Gonal-f® RFF Redi-ject After Single Subcutaneous Application

Healthy Volunteers

United Kingdom
ZZ Biotech, LLC

Completed

Safety and Pharmacokinetics of Single and Multiple Ascending Doses of 3K3A-APC in Healthy Adult Volunteers

Healthy

Austria
GenMont Biotech Incorporation

Completed

Effects of Genmont Probiotic on Improve the Level of Blood Glucose and Other Diabetic Associate Parameter in Type 2 Diabetes Patients

Type 2 Diabetes

Taiwan
Andromeda Biotech Ltd.

Completed

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults (DIA-AID2)

Type 1 Diabetes Mellitus

United States, Russian Federation, Israel, Spain, Lithuania, Germany, Austria, Belarus, Canada, Czech Republic, Finland, Hungary, Italy, Poland
SciVision Biotech Inc.

Withdrawn

Safety and Efficacy Study of Lidocaine Mixed Hyaluronate on Nasolabial Folds Correction

Pain | Nasolabial Folds Correction

Taiwan
Steba Biotech S.A.

Terminated

Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma

Cholangiocarcinoma

France
Folia Biotech Inc.

Unknown

Safety and Reactogenicity of a PAL Combined With Seasonal Flu Vaccine in Healthy Adults

Flu

Canada
Siena Biotech S.p.A.

Completed

A Phase II Safety and Tolerability Study With SEN0014196

Huntington's Disease

Germany
Janssen Biotech, Inc.

Completed

An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

United States
Steba Biotech S.A.

Completed

Study Using WST11 in Patients With Localized Prostate Cancer

Prostate Cancer

Netherlands, France, United Kingdom
Active Biotech AB

Completed

ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States, Denmark, Russian Federation
Mentrik Biotech, LLC

Unknown

Phase I Study of Subcutaneous Ocaratuzumab in Patients With Previously Treated CD20+ B-Cell Malignancies

Previously Treated CD20+ B-cell Malignancies

United States
Andromeda Biotech Ltd.

Completed

Long-Term Treatment Effect of DiaPep277 in Type 1 Diabetes

Type 1 Diabetes

Israel
Facet Biotech
Biogen

Terminated

A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer

Peritoneal Neoplasms | Ovarian Cancer

United States, Canada
Lorenz Biotech S.p.A.

Completed

Frequency Modulated Neural Stimulation (FREMS) in Symptomatic Diabetic Neuropathy

Diabetic Neuropathy, Painful

France, Germany, Italy
Olympus Biotech Corporation

Completed

OP Device vs. Bone Autograft for the Treatment of Tibial Nonunions

Tibial Nonunions

United States
Olympus Biotech Corporation

Completed

OP-1 Putty for Posterolateral Fusions

Degenerative Lumbar Spondylolisthesis

United States, Canada
Kenta Biotech Ltd

Completed

Safety and Pharmacokinetics of KBPA-101 in Hospital Acquired Pneumonia Caused by O11 Pseudomonas Aeruginosa

Pneumonia | Ventilator Associated Pneumonia

Switzerland
Cura Biotech LLC

Unknown

A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis

Osteoarthritis | Rheumatoid Arthritis

United States
Welichem Biotech Inc.

Completed

Double-Blind Study of Topical WBI-1001 Cream on Patients With Psoriasis (WBI-1001-101)

Psoriasis

Canada
BioNTech US Inc.

Recruiting

NEO-PTC-01 in Patients With Advanced or Metastatic Melanoma

Metastatic Melanoma | Unresectable Melanoma

Belgium, Netherlands, Spain
Xuanwu Hospital, Beijing
Beijing Mario Biotech Company; Hebei Senlang BIotech Company; Beijing HuiNengAn...

Recruiting

Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas

Glioma | Malignant Glioma of Brain | Recurrence Tumor

China
Sinovac Biotech (Hong Kong) Limited

Completed

Immunogenicity and Safety Study of Booster Vaccine With the COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain

COVID-19

China
BioNTech Research & Development, Inc.

Recruiting

Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies

Pancreatic Cancer

United States
BioNTech RNA Pharmaceuticals GmbH

Completed

RBL001/RBL002 Phase I Clinical Trial (MERIT)

Melanoma

Austria, Germany
BioNTech Research & Development, Inc.

Terminated

Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Radioimmunotherapy

Pancreatic Carcinoma | Tumors That Express CA 19-9

United States
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

Safety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine （CHO Cell）LYB002V14 in Booster Vaccination

SARS-CoV-2 | COVID-19 Vaccine

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Active, not recruiting

Safety and Immunogenicity of COVID-19 Vaccine in Population Aged 18 Years and Above

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years

Herpes Zoster

Australia
SOTIO Biotech AG
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

Hepatocellular Carcinoma | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Castration-resistant Prostate Cancer | Cutaneous Squamous Cell Carcinoma

Italy, Spain, France, Belgium, Czechia, United States, Poland, Georgia, Hungary
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Terminated

Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Withdrawn

Immunogenicity and Safety of COVID-19 Vaccine in Population Aged 18 Years and Above

COVID-19

China
BioNTech SE

Recruiting

A Clinical Trial in Healthy Volunteers to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions

Genital Herpes Simplex Type 2

United States
XBiotech, Inc.

Recruiting

Natrunix or Placebo in Combination With Methotrexate in Rheumatoid Arthritis

Rheumatoid Arthritis

United States
XBiotech, Inc.

Not yet recruiting

Natrunix Versus Methotrexate in Rheumatoid Arthritis

Rheumatoid Arthritis

Clinical Trials Sponsored by ARCEDI Biotech

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations